Lee’s Pharmaceutical Board to Review Mid-Year Results

Lee’s Pharmaceutical Holdings Limited (HK:0950) has released an update.

Lee’s Pharmaceutical Holdings Limited has announced that their Board of Directors will convene on August 28, 2024, to discuss and potentially approve the unaudited interim results for the first half of the year and to consider declaring an interim dividend. The meeting is scheduled to take place at the company’s headquarters in the Hong Kong Science Park. Shareholders and investors are advised to anticipate potential updates on the company’s financial performance and dividend payouts.

For further insights into HK:0950 stock, check out TipRanks’ Stock Analysis page.